PEGylation – a well-proven strategy for the improvement of recombinant drugs

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.69, Iss.5, 2014-05, pp. : 323-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

PEGylation of Interferon-β-1a: A Promising Strategy in Multiple Sclerosis

By Kieseier Bernd C.

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 205-214

Adis International

Access to resources Recommend Favorite

PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery

Current Drug Metabolism, Vol. 13, Iss. 1, 2012-01 ,pp. : 105-119

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic and recombinant antithrombin drugs

By Kaiser B. Callas D. Walenga J.M. Fareed J.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 6, 1998-06 ,pp. : 963-985

Informa Healthcare

Access to resources Recommend Favorite

New strategy against counterfeit drugs in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 545, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 3, 2011-01 ,pp. : 230-245

Bentham Science Publishers

Access to resources Recommend Favorite